Wedbush Expects Weaker Earnings for Voyager Therapeutics
Equities research analysts at Wedbush reduced their Q1 2025 earnings per share estimates for shares of Voyager Therapeutics ...
Analysts Have Conflicting Sentiments on These Healthcare Companies: Teleflex (TFX) and Voyager Therapeutics (VYGR)
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Teleflex (TFX – Research Report) and Voyager Therapeutics ...
ETF Daily News3d
HC Wainwright Has Optimistic Outlook of VYGR Q1 Earnings
Shares of VYGR stock opened at $3.89 on Monday. Voyager Therapeutics has a 12-month low of $3.56 and a 12-month high of $10.66. The firm has a market capitalization of $212.50 million, a price-to ...
Analysts Offer Insights on Healthcare Companies: Voyager Therapeutics (VYGR), Labcorp Holdings (LH) and Arcutis Biotherapeutics (ARQT)
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Voyager Therapeutics (VYGR – Research Report), ...
A Glimpse Into The Expert Outlook On Voyager Therapeutics Through 4 Analysts
Analysts have set 12-month price targets for Voyager Therapeutics, revealing an average target of $18.93, a high estimate of ...
Voyager Reports Fourth Quarter and Full Year 2024 Financial and Operating Results
Tau silencing gene therapy VY1706 robustly reduced tau mRNA levels, with broad distribution, and was well-tolerated in NHP ...
Nasdaq11d
VOYAGER THERAPEUTICS Earnings Preview: Recent $VYGR Insider Trading, Hedge Fund Activity, and More
VOYAGER THERAPEUTICS ($VYGR) is expected to release its quarterly earnings data on Tuesday, March 11th after market close, per Finnhub. Analysts are expecting revenue ...
Zacks Investment Research on MSN9d
Voyager Therapeutics (VYGR) Reports Q4 Loss, Misses Revenue Estimates
Voyager Therapeutics (VYGR) came out with a quarterly loss of $0.59 per share versus the Zacks Consensus Estimate of a loss of $0.35. This compares to earnings of $1.25 per share a year ago. These ...